---
title: "Bedrosian Camille L — Ownership Dossier"
canonical: https://whiteintel.dev/entity/dcbd110f-9579-5e8e-af46-446d265a18ad
json: https://whiteintel.dev/api/public/dossier/dcbd110f-9579-5e8e-af46-446d265a18ad
identifier: sec:0001326969
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Bedrosian Camille L

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001326969`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/dcbd110f-9579-5e8e-af46-446d265a18ad  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/dcbd110f-9579-5e8e-af46-446d265a18ad  

## Ownership & control

### Holdings / subsidiaries

- **Amylyx Pharmaceuticals, Inc.** (officer) — https://whiteintel.dev/entity/9406e386-c399-56ce-9f78-0b28d2649efb
- **Crinetics Pharmaceuticals, Inc.** (director) — https://whiteintel.dev/entity/ed73e2a0-da3d-5ece-a64d-633008d3b62c
- **Amylyx Pharmaceuticals, Inc.** (officer) — https://whiteintel.dev/entity/9406e386-c399-56ce-9f78-0b28d2649efb
- **RHYTHM PHARMACEUTICALS, INC.** (director) — https://whiteintel.dev/entity/fa951071-e445-5c3f-9817-53aaddc9e6a0
- **Ultragenyx Pharmaceutical Inc.** (officer) — https://whiteintel.dev/entity/7676cfa8-af2d-5710-9e6d-eba8103dad46
- **ARIAD PHARMACEUTICALS INC** (officer) — https://whiteintel.dev/entity/779d9c9c-607f-5f52-bb57-b77273ced10d

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Bedrosian Camille L**. Human view: https://whiteintel.dev/entity/dcbd110f-9579-5e8e-af46-446d265a18ad · Structured JSON: https://whiteintel.dev/api/public/dossier/dcbd110f-9579-5e8e-af46-446d265a18ad._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._